~~<i id='D4FC8D8362'><strike id='D4FC8D8362'><tt id='D4FC8D8362'><pre id='D4FC8D8362'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

Wikipedia

fashion

author：leisure time 2025-10-01 13:58:41 - browse：5637

Michel Pairet -- health business coverage from STAT — Michel Pairet Courtesy Boehringer Ingelheim

LONDON — At an event here last week, the German pharmaceutical firm Boehringer Ingelheim outlined the projects in its pipeline.

There was obesity and liver disease, and computational biology and oncology. Then respiratory and inflammatory diseases. And don’t forget mental illness and retinal health. Oh, it was also the day the company launched another Humira biosimilar.

In other words, there was a whole lot for the company to discuss as it works to promote its breadth and build partnerships with academic researchers and other companies.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： Positive childhood experiences can help future health

focus

hotspot

knowledge

Wikipedia

Anexamroominawomen'shealthcenterinIndiana,whereabortionsarenowbannedwithverylimitedexceptions.ScottO

WSS

AstraZeneca to buy developer of next

Argenx readies a blockbuster opportunity with drug for autoimmune disease

I was wrong about Geron's blood cancer drug. Now, is it a takeover target?

Leading voice in opioid treatment defends methadone clinic system

Sen. Paul opposes bill to ban Chinese biotechs

Novo Nordisk obesity pill bests Wegovy in early trial

Wikipedia

fashion

focus

Hollywood unions extend contract negotiations for actors

Physicians and social media: If you see something, say something?

Supreme Court strikes down use of affirmative action

Amylyx ALS drug failure raises questions and concerns

23andMe had bad news about my health. I wish a person had delivered it

Virtual Event: March of the Biosimilars

23andMe had bad news about my health. I wish a person had delivered it

Nurses recount patients attacks

Medical records are filled with copy

I was wrong about Geron's blood cancer drug. Now, is it a takeover target?

focus

Health AI adoption puts security, privacy startups on investors' radar

UnitedHealth quietly bought dozens of outpatient centers

App could help diagnose ear infections more accurately — and at home

Physicians and social media: If you see something, say something?

In surprise move, FDA calls for advisory committee on Lilly's Alzheimer's drug

Creating egg and sperm cells from stem cells raises ethical issues

hotspot

hotspot

knowledge

Wikipedia